Eli Lilly to acquire Centessa Pharmaceuticals under definitive agreement
Acquisition to include orexin receptor portfolio for sleep and neurological conditions
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Granules Life Sciences receives VAI classification following US FDA inspection
Granules India announced that its wholly owned subsidiary, Granules Life Sciences (GLS), has concluded a recent US FDA inspection…
Rusan unveils APOSAN 3ml multi-dose pen for treatment of motor fluctuations
Rusan Healthcare, the marketing and distribution arm of Rusan Pharma, an integrated global pharmaceutical company, has announced…
CORONA Remedies announces strategic acquisition of Wokadine in India
CORONA Remedies announced the acquisition of Wokadine from Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered…
HRV Pharma, Shodhana partner to accelerate next-gen API development
HRV Pharma, India's first integrated Virtual API and Pharmtech company announced a comprehensive, multi-year Contract Development…
Shreehas Tambe appointed CEO & MD of Biocon, effective April 1, 2026
Biocon announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1,…
India’s opportunity to lead next generation injectable drug innovation
India is rapidly evolving into a global hub for generic injectable drugs, driven by rising disease burden, cost efficient…
Kinny Singh appointed Deputy Secretary in Department of Pharmaceuticals
IAS officer Kinny Singh has been appointed as Deputy Secretary in the Department of Pharmaceuticals under the Central Staffing…
Lupin receives tentative approval from US FDA for Pitolisant tablets
Global pharma major Lupin announced that it has received tentative approval from the United States Food and Drug Administration…
Ministry of Ayush and DBT announce collaborative clinical study on ayurveda as adjunct therapy for…
On the occasion of World Tuberculosis (TB) Day, the Union Ministry of Ayush in partnership with the Department of Biotechnology…
DCGI launches nationwide drive to curb illegal sale of GLP-1 drugs
In a significant move to uphold ethical pharma practices and safeguard public health, the Drugs Controller General of India has…
PHDCCI hosts ‘NutraVision 2026’ to chart future of India’s nutra sector and global wellness…
The PHD Chamber of Commerce and Industry (PHDCCI) successfully convened the landmark conference “NutraVision 2026: Defining the…
Godavari Biorefineries secures Japanese Patent for antiviral compounds targeting viral infections
Godavari Biorefineries has secured a patent from the Japan Patent Office (JPO) for its invention titled "Use of Compounds for…
NIPER Raebareli, Roche Pharma partners to strengthen pharma education and research capability
Roche Pharma India signed a Memorandum of Understanding (MoU) with National Institute of Pharmaceutical Education and Research…
USV launches “usema” to address India’s metabolic health burden
USV Private, an Indian multinational healthcare company and a leader in diabetes care, announced the launch of usema, in…
India’s Pharma giants race to launch Semaglutide, intensifying GLP-1 market competition
India’s leading pharma companies have simultaneously forayed into the semaglutide segment, marking a major shift in the country’s…
BIRAC fuels innovation with Rs. 4,200 crore funding across 15 lakh startups and entrepreneurs
Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise set up by the Department of Biotechnology…
Lupin Manufacturing Solutions announces expansion of manufacturing facility at Dabhasa
Lupin Manufacturing Solutions (LMS), a global CRDMO and subsidiary of global pharma major Lupin Limited (Lupin), today announced a…
Eris launches weekly shot of Semaglutide starting at ₹220 per shot
Eris Lifesciences, a leading Indian branded formulations company, today announced a breakthrough step in expanding access to…
Glenmark Pharmaceuticals USA launches authorised generic to Milnacipran Hydrochloride tablets
Glenmark Pharmaceuticals USA announces the launch of Milnacipran Hydrochloride tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg.…